HA. Impaired myogenic constriction of the renal afferent arteriole in a mouse model of reduced ␤ENaC expression. Am J Physiol Renal Physiol 302: F1486 -F1493, 2012. First published March 14, 2012 doi:10.1152/ajprenal.00638.2011.-Previous studies demonstrate a role for ␤ epithelial Na ϩ channel (␤ENaC) protein as a mediator of myogenic constriction in renal interlobar arteries. However, the importance of ␤ENaC as a mediator of myogenic constriction in renal afferent arterioles, the primary site of development of renal vascular resistance, has not been determined. We colocalized ␤ENaC with smooth muscle ␣-actin in vascular smooth muscle cells in renal arterioles using immunofluorescence. To determine the importance of ␤ENaC in myogenic constriction in renal afferent arterioles, we used a mouse model of reduced ␤ENaC (␤ENaC m/m) and examined pressure-induced constrictor responses in the isolated afferent arteriole-attached glomerulus preparation. We found that, in response to a step increase in perfusion pressure from 60 to 120 mmHg, the myogenic tone increased from 4.5 Ϯ 3.7 to 27.3 Ϯ 5.2% in ϩ/ϩ mice. In contrast, myogenic tone failed to increase with the pressure step in m/m mice (3.9 Ϯ 0.8 to 6.9 Ϯ 1.4%). To determine the importance of ␤ENaC in myogenic renal blood flow (RBF) regulation, we examined the rate of change in renal vascular resistance following a step increase in perfusion pressure in volume-expanded animals. We found that, following a step increase in pressure, the rate of myogenic correction of RBF is inhibited by 75% in ␤ENaC m/m mice. These findings demonstrate that myogenic constriction in afferent arterioles is dependent on normal expression of ␤ENaC.
Our laboratory has considered epithelial Na ϩ channel (ENaC) proteins as candidates for the mechanosensor because they have a strong evolutionary link to mechanosensing. ENaC proteins are members of the same protein family as nematode Caenorhabditis elegans degenerin proteins and share amino acid homology and a common structure of intracellular NH 2 and COOH termini, two membrane-spanning domains, and a large extracellular domain (1, 10, 19, 33) . A substantial body of evidence demonstrates that nematode degenerin proteins form the ion-conducting pore of mechanosensors in neurons and muscle (10, 33) . Therefore, the strong evolutionary link to nematode mechanosensing provides a reasonable basis that certain ENaC proteins may also function as a mechanosensor.
At least one specific ENaC protein, ␤ENaC, is essential to transduction of myogenic constriction in renal interlobar arteries. ␤ENaC is expressed in renal vascular smooth muscle cells (VSMCs) (14, 15) . Transient gene silencing, using smallinterfering RNA (siRNA) or dominant-negative constructs, demonstrates inhibition of ␤ENaC alone is sufficient to nearly abolish myogenic constriction in mouse renal interlobar arteries (14) . Although the interlobar artery is a small resistance artery (ϳ75-100 m diameter), the role of ␤ENaC in the myogenic response must be extended to vascular beds that generate most of the renal vascular resistance to be physiologically relevant. A few recent pharmacological studies have addressed the importance of ENaC proteins on the afferent arteriolar (primary site of renal vascular resistance) myogenic response using broad-spectrum ENaC channel inhibitors amiloride and benzamil with equivocal results (12, 37) . Thus, the importance of ENaC protein-mediated afferent arteriolar myogenic constriction remains unresolved.
The goal of this study was to determine the importance of ␤ENaC in myogenic constriction of the afferent arteriole by using a genetically modified mouse model with reduced levels of ␤ENaC (␤ENaC m/m). The ␤ENaC m/m model was generated using standard gene-targeting approaches in the course of generating a model of Liddle's syndrome (increased ␤ENaC) by inserting a premature stop codon in the COOHterminus coding region. However, the presence of the neomycin selection marker disrupts the ␤ENaC gene locus, resulting in reduced ␤ENaC expression. Thus, a mouse model that under-, rather than overexpresses, ␤ENaC was generated (27) . Mice homozygous for the mutation (m/m) express very low levels of ␤ENaC transcripts and protein in the lung and kidney as well as reduced ␤ENaC protein in cerebral VSMCs (11, 27, 38) . We found that 1) ␤ENaC is localized in small renal arterioles in wild-type animals, 2) myogenic constriction of the afferent arteriole using the intact afferent arteriole-glomerulus preparation is nearly abolished in the ␤ENaC m/m, and 3) loss of ␤ENaC-mediated myogenic constriction contributes to a loss of myogenic regulation of whole kidney blood flow immediately after a change in blood pressure. Results of this investigation demonstrate that ␤ENaC mediates myogenic constriction in renal afferent arterioles and contributes to regulation of whole kidney blood flow.
METHODS
Studies were conducted in genetically modified mice. Heterozygote ␤ENaC ϩ/m mating pairs on a mixed genetic background were generously provided by E. Hummler and B. Rossier (University of Lausanne, Lausanne, Switzerland). Animals were provided standard rodent chow containing 0.4% Na ϩ (Teklad) and water ad libitum. Offspring of heterozygote mating pairs were genotyped at 3 wk of age using DNA isolated (DirectTail PCR; Viagen) from tail samples and reconfirmed following phenotypic analysis using liver samples as previously described (38) . The University of Mississippi Medical Center's Institutional Animal Care and Use Committee approved all animal protocols. Animals were exposed to 12:12-h light (0600 -1800)-dark (1800 -0600) cycles.
Protocol 1: Localization of ␤ENaC in small renal arterioles. We used confocal microscopy to localize ␤ENaC in small arterioles in paraformaldehyde-fixed, frozen renal sections. For these experiments, kidneys from adult ␤ENaC ϩ/ϩ and m/m littermates were harvested and postfixed in 4% paraformaldehyde overnight. The kidneys were rinsed in phosphate buffer salt solution (PBS), embedded in freezing medium, and sectioned at 40 m. For staining, sections were thoroughly air-dried, then rinsed with PBS and blocked with 5% normal donkey serum (NDS) for 1 h at 37°C. Samples were incubated with affinity-purified rabbit anti-␤ENaC developed in our laboratory (1: 100, 1 h, 37°C) and mouse smooth muscle ␣-actin (1:100; Sigma Chemicals) as a positive control for VSMCs (14, 38) . Samples without primary antibody served as an additional negative control. Samples were rinsed three times with PBS and incubated with Alexa 488-conjugated donkey anti-mouse IgG (1:1,000; Invitrogen) and Cy3-conjugated donkey anti-rabbit Fab (1:100; Jackson Immunologicals) in 5% NDS for 1 h at 37°C. Samples from ϩ/ϩ and m/m kidneys were rinsed in PBS, mounted with GelMount, covered with a cover slip, and examined under identical conditions using a Leica TSC-SP2 laser scanning confocal microscope. Images were prepared identically for presentation in Adobe Photoshop.
Protocol 2: Determination of myogenic constriction of mouse afferent arterioles. To evaluate myogenic constrictor responses in the afferent arteriole of ␤ENaC mice, we used methods described previously (22, 28) . Briefly, male ␤ENaC ϩ/ϩ (8.2 Ϯ 1.7 wk) and m/m (8.0 Ϯ 0.6 wk) mice were anesthetized with isoflurane, and kidneys were removed and thinly sliced along the corticomedullary axis. Slices were placed in ice-cold minimum essential medium (MEM; GIBCO, Grand Island, NY) containing 5% bovine serum albumin (BSA), and single superficial glomeruli with an attached afferent arteriole were microdissected under a stereomicroscope (model SMZ 1500; Nikon). Afferent arteriole-glomerulus complexes were dissected within 90 min at 8°C. The isolated afferent arteriole and attached glomerulus were transferred to a temperature-regulated chamber mounted on an inverted microscope (Eclipse Ti; Nikon) cannulated with an array of glass pipettes and gradually warmed to 37°C. The afferent arterioles were perfused with MEM from the proximal end in an orthograde direction and gently pressurized to 60 mmHg. Following a 30-min equilibration period, images were collected to determine afferent arteriole internal diameter. The imaging system consisted of a microscope (Eclipse Ti; Nikon), digital CCD camera (CoolSnap; Photometrics), xenon light (LB-LS/30; Shutter Instruments), and optical filter changer (Lambda 10 -3; Shutter Instruments). Images were displayed and analyzed with NIS-Elements imaging software (Nikon). To determine the active response to pressure, perfusion pressure was increased from 60 to 120 mmHg for 5 min, and another image was collected. To determine passive response, the perfusion pressure was lowered to 60 mmHg, and the perfusion and bathing solutions were exchanged with a Ca 2ϩ -free MEM and reequilibrated for another 30 min. The response to a 60-mmHg step increase in pressure was repeated under Ca 2ϩ -free conditions. At the end of the experiment, the arteriolar segments were reequilibrated with Ca 2ϩ MEM at 60 mmHg, and the vasoconstrictor response to the ␣-adrenergic receptor agonist norepinephrine (NE, 10 Ϫ5 M) was obtained. Myogenic tone was calculated as (diameter Ca 2ϩ free -diameter Ca 2ϩ plus)/diameter Ca 2ϩ free. The sensitivity of the response was quantified as the slope of the pressure-myogenic tone relationship at 60 and 120 mmHg.
Previous studies in our laboratory have used the renal interlobar artery to study the renal myogenic response; however, concern that myogenic activity of the small artery may not behave similarly to the afferent arteriole has been raised. To determine if the small renal interlobar artery is similarly affected, we evaluated myogenic constriction as previously described (14, 15) in interlobar arteries from a small group of ␤ENaCϩ/ϩ (n ϭ 3; 14 Ϯ 1 wk of age; female) and mice harboring one or two mutant alleles (m/m or ϩ/m; n ϭ 5, 14 Ϯ 1 wk of age; female).
Protocol 3: Determination of myogenic renal blood flow regulation. To gain further insight into the importance of ␤ENaC-mediated myogenic control of renal blood flow (RBF), we evaluated RBF and renal vascular resistance (RVR) responses to a step increase in perfusion pressure under conditions where tubuloglomerular feedback (TGF), a slower mechanism involved in the control of RBF, was suppressed by volume expansion (9, 18, 26, 30, 35, 37) .
Determination of RBF regulation was conducted as described previously (11) with a few significant modifications. Mice were maintained under isoflurane anesthesia on a heating pad to maintain body temperature at 37°C (rectal) for the duration of the study. The depth of anesthesia was monitored by the response to toe pinching. Mice were instrumented with a fluid-filled carotid artery catheter to measure mean arterial pressure (MAP) and a jugular vein catheter for fluid infusion. For determination of RBF, the left kidney was approached through a retroperitoneal flank incision. The renal artery, celiac artery, mesenteric artery, and lower abdominal aorta were freed from adjacent tissue. The celiac and superior mesenteric arteries were ligated, and a temporary ligature was placed around the lower abdominal aorta. A perivascular flow probe (0.5 PSB; Transonic, Ithaca, NY) was positioned on the left renal artery. RBF was measured using an ultrasound transit-time flowmeter (TS420, low-pass filter 30 -40 Hz; Transonic) recorded, along with blood pressure, with a computerized chart recorder (LabChart 6.0, PowerLab; ADInstruments, Colorado Springs, CO). After 10 min of stabilization, a blood volume expansion (equivalent to 5% body weight) was initiated to suppress TGF contribution to RBF regulation, an approach used by others (9, 18, 26, 30, 35, 37) . The volume expansion was accomplished by infusing a 5% BSA solution in lactated Ringer solution delivered at 100 l/min (10-to 15-min infusion). Following this period, 20 min were allowed for equilibration. To achieve a 10-to 15-mmHg step increase in MAP, the ligature around the lower abdominal aorta was tightened. At the conclusion of the experiments, the animals were killed by an overdose of isoflurane followed by decapitation. MAP and RBF data were recorded at 1,000 Hz. RBF was normalized to left kidney weight and reported as milliliters per minute per gram kidney weight. RBF responses were obtained in 7 m/m (3 females, 4 males) and 6 ϩ/ϩ (2 females, 4 males) littermate controls.
Data analysis for RBF regulation. RVR was calculated as MAP/ RBF and reported as resistance units (RU ϭ mmHg·ml Ϫ1 ·min Ϫ1 ·g kidney wt Ϫ1 ). To quantify the RVR response to changes in perfusion pressure, we continuously recorded pressure and RBF for at least 10 s before and 30 s after a step increase in pressure. The contribution of myogenic regulation to steady-state RBF cannot be assessed from this investigation because the myogenic and TGF responses are suppressed, but not abolished, and residual activity from these mecha-nisms and an intact "third mechanism" will contribute to steady-state RBF regulation. Data were extracted and averaged over each 1-s interval in LabChart and exported to Microsoft Excel for further analysis. The first time point where MAP increased 5% or more above baseline was used to identify the zero time point. Responses were normalized to control baseline values. The sensitivity of the myogenic mechanism was assessed by the slope of the time-RVR relationship between 0 and 5 s [i.e., the rate of correction of RVR during the time frame where the myogenic mechanism is active as previously shown by Just and Arendshorst (16)].
Statistical analysis. All data are presented as means Ϯ SE. Data were analyzed using paired or unpaired t-test with one (predicted direction of response) or two tails where appropriate. We also used repeated-measures ANOVA followed by a Student-Neuman-Keuls post hoc test for differences among the means where appropriate. Statistical significance was set at P Ͻ 0.05. Specific P values are provided for certain data sets to demonstrate the high level of confidence in our statistical analyses.
RESULTS
␤ENaC localization in VSMC of small renal arterioles. We used confocal microscopy to localize ␤ENaC in small renal arterioles. In preliminary studies, we were unable to detect ␤ENaC immunolabeling in renal vasculature in paraffin-embedded renal sections. Because others and we have previously demonstrated ␤ENaC immunolabeling in enzymatically dissociated renal VSMCs, we considered the possibility that the lack of signal was due "antigen blockade." To address this, we used proteinase K treatment. Following treatment with proteinase K, a small but consistent signal difference was observed in renal vascular tissue between ϩ/ϩ and m/m mice; however, general background staining was also enhanced. We then turned to frozen renal sections. Using frozen sections, we could identify brightly stained portions of the distal cortical nephron (Fig. 1C) and less well-stained vascular tissue. Although vascular ␤ENaC labeling was weak relative to the tubules, ␤ENaC labeling in the vasculature was consistently greater in ϩ/ϩ vs. m/m mice (Fig. 1, A and B) . ␤ENaC localization in afferent arterioles is shown in a cross section (Fig. 1A ) and longitudinal section (Fig. 1B) adjacent to the glomerular border. The studies were repeated in two separate trials. Immunolabeling was absent in the no primary antibody negative controls.
Afferent arteriole myogenic constriction is inhibited in ␤ENaC m/m mice. We examined myogenic constrictor responses in ␤ENaC ϩ/ϩ and m/m mice using the isolated afferent arteriole-attached glomerular preparation ( Fig. 2A) . The average inner diameter of renal afferent arterioles before and after a step increase in intraluminal pressure under Ca 2ϩ - containing and Ca 2ϩ -free conditions in ϩ/ϩ and m/m mice is shown in Fig. 2B . When pressure is raised from 60 to 120 mmHg, afferent arterioles from ␤ENaC ϩ/ϩ mice constrict to below resting diameter (P ϭ 0.003, paired t-test); however, the diameter remains steady in m/m mice (P ϭ 0.099, paired t-test). Under Ca 2ϩ -free conditions, the afferent arterioles from ϩ/ϩ and m/m mice passively dilate with the step increase in pressure (P ϭ 0.013 for ϩ/ϩ and m/m groups, paired t-test; Fig. 2B ). The significance of the increased diameter of the ␤ENaC m/m afferent arteriole, compared with ϩ/ϩ, is not clear. Under Ca 2ϩ conditions, it may reflect a loss of basal myogenic tone. However, under Ca 2ϩ -free conditions, it may reflect vascular remodeling that has occurred over the life span of the animal. When calculated as myogenic tone, afferent arterioles from ϩ/ϩ mice generate nearly 27 Ϯ 5% (n ϭ 6) myogenic tone at 120 mmHg; however, afferent arterioles from m/m mice generate 7 Ϯ 1% (n ϭ 6, P ϭ 0.003) (Fig. 2C) . Constrictor responses to 10 Ϫ5 M NE were similar between ϩ/ϩ and m/m groups, suggesting afferent arterioles from ␤ENaC m/m do not have a generalized loss in their ability to vasoconstrict, but rather have a deficit in their ability to constrict in response to pressure (Fig. 2D) .
To determine whether the myogenic response is also altered in small renal arteries, we examined myogenic constriction in renal interlobar artery segments (Fig. 2, E-G) . For these experiments, data from mice harboring one or two ␤ENaC mutant alleles were combined. While myogenic tone increases with increasing pressure in ϩ/ϩ animals, tone remains flat in mice with the ␤ENaC mutant gene(s) (Fig. 2E ). Constriction to phenylephrine and KCl was not different (Fig. 2, F and G) . These findings suggest that ␤ENaC also plays an important role in myogenic tone in renal interlobar arteries.
Myogenic regulation of RBF is impaired in ␤ENaC m/m mice. Baseline MAP, RBF, and RVF were not different between ϩ/ϩ and m/m mice (Table 1 and Fig. 3, A-C) . The temporal responses of MAP, RBF, and RVR following the volume expansion protocol are presented as absolute data (Fig.  3, A-C) and normalized as the percentage of baseline (Fig. 3 , 
D-F).
With the step increase in perfusion pressure, MAP increases ϳ10 mmHg (15%) and remains elevated in ϩ/ϩ and m/m groups (Fig. 3, A and D) . The change in MAP between baseline and 20 -30 s was not different between ϩ/ϩ and m/m mice (Fig. 3A, right) . RBF increases transiently with the increase in MAP in both ϩ/ϩ and m/m mice (Fig. 3, B and E) . Although RBF returns to baseline levels by 30 s in ϩ/ϩ, it remains elevated in m/m mice (Fig. 3, B and E) . At 20 -30 s, the change in RBF from baseline was significantly greater in m/m mice (Fig. 3B, right) . RVR falls transiently with the step increase in MAP as expected due to passive compliance (Fig. 3, C and F) . In ϩ/ϩ animals, the decrease in RVR is followed by an initial rapid increase within the first 5s (the expected time frame for initiation of the myogenic response), followed by a slower secondary increase. In m/m animals, the rapid increase in RVR is less dramatic (Fig. 3,  C and F) . To investigate the speed of the myogenic mechanism, we calculated the slope of the linear regression lines for RVR between 0 and 5 s. The speed of the myogenic mechanism is reduced in ␤ENaC m/m (RVR 0 -5 s , 0.08 Ϯ 0.09 vs. 0.36 Ϯ 0.06 RU/s, P ϭ 0.014) (Fig. 3F, inset) . At 20 -30 s, the increase in RVR from baseline was significantly less in m/m mice (Fig. 3B, right) . These data suggest the apparent speed of the myogenic response is reduced by more than fourfold in ␤ENaC m/m mice. As shown in Table  2 , 30 s following the pressure step, RBF (%baseline) is significantly greater and RVR significantly lower, in the ␤ENaC m/m vs. ϩ/ϩ. These findings suggest the deficit in Table 1 the myogenic mechanism delays the correction of RBF and RVR following a change in perfusion pressure.
DISCUSSION
Previous studies have suggested certain members of the degenerin protein family may contribute to the transduction of the myogenic response. Because degenerin proteins are closely related to proteins thought to form the pore of a large mechanosensor in the nematode, we suspect that they may also form the pore of a mechanosensor in renal VSMCs. ␤ENaC is one degenerin expressed in renal VSMCs. Transient inhibition of ␤ENaC inhibits myogenic constriction in renal interlobar arteries. However, the importance of ␤ENaC in myogenic constriction of renal afferent arterioles, the primary site of vascular resistance development in the kidney, is not clear. In the current investigation, we determined the importance of ␤ENaC in renal afferent arteriolar myogenic response in a mouse model of reduced ␤ENaC (␤ENaC m/m). Here, we provide evidence that 1) ␤ENaC is expressed in small renal arterioles, 2) myogenic constriction of afferent arterioles is inhibited in ␤ENaC m/m, and 3) myogenic regulation of RBF is inhibited in ␤ENaC m/m mice.
Role of ␤ENaC as a mechanosensor. ENaC proteins are members of a larger, novel family of proteins termed degenerins. Degenerins were first identified in the nematode where chemically induced mutations caused neurons to swell and lyse, or degenerate, hence the name degenerin. Subsequent studies demonstrated that nematode degenerin proteins likely form the pore of large, heteromeric mechanosensors present in neurons and muscle (10, 32, 33) . Because ENaC proteins are evolutionarily related to mechanosensory nematode mechanosensor proteins, they have been considered as potential mammalian mechanosensors (7, 8, 10, 32) . In support of this possibility, mammalian degenerins have been identified in mechanosensitive tissues such as sensory neurons, bone cells, and smooth muscle cells (2, 21, 34, 36) . Our laboratory has focused on the role of ␤ENaC in VSMC mechanotransduction. A hypothetical model of a mammalian mechanosensor in VSMCs, based on the C. elegans model, is shown in Fig. 4 . In this model, degenerin proteins form the ion-conducting pore. We hypothesize that ␤ENaC contributes to the pore. The pore is tethered to the extracellular matrix and cytoskeleton, either directly or indirectly. Gating of the complex by mechanical forces allows influx of Na ϩ , which then leads to membrane depolarization and initiates the signaling cascade leading to VSMC contraction.
Evidence suggests ␤ENaC plays an important role in mediating the myogenic response in renal vessels. ␤ENaC protein is localized at or near the cell surface of renal VSMCs. Inhibition of ␤ENaC expression, using siRNA and dominant-negative isoforms, inhibits myogenic constriction in renal interlobar arteries. However, the importance of ␤ENaC in myogenic constriction of renal afferent arterioles, the primary site of vascular resistance development in the kidney, is not clear. A few recent investigations have addressed the importance of ENaC protein family members in afferent arteriolar myogenic constriction using broad-spectrum inhibitors, such as amiloride and benzamil (12, 39) ; however, these studies have not provided a clear picture of the importance of ENaC proteins. To address the importance of ␤ENaC, we turned to a genetically modified mouse model, since it offers the advantage of target specificity over pharmacological approaches. For the experiments described in this investigation, we used the ␤ENaC m/m model with low expression of ␤ENaC. We used this model rather than a traditional knockout model since complete elimination of ␤ENaC by knockout is lethal shortly after birth (25) .
Importance of ␤ENaC in renal afferent arteriolar myogenic constriction. A previous study showed that transient ␤ENaC gene-silencing approaches in renal interlobar arteries suppressed myogenic constriction (11) . The findings of our current study are consistent with this earlier study: myogenic constriction in interlobar artery segments is inhibited in ␤ENaC m/m mice. Furthermore, findings from the current study indicate that myogenic constriction in the afferent arteriole, the primary site of RVR development, is also mediated by ␤ENaC. Therefore, these findings suggest ␤ENaC plays an important role in transduction of the myogenic response in afferent arterioles and small arteries of the renal vasculature.
Importance of myogenic constriction in RBF regulation. In response to a change in renal perfusion pressure, RBF is maintained constant by the concerted action of at least two mechanisms (myogenic constriction and TGF). Myogenic constriction is fast acting, adjusting vascular resistance to a change in perfusion pressure within 5-10 s, while TGF is slower, Values are means Ϯ SE; n, no. of mice. *P value from 2-tailed t-test.
Fig. 4. Hypothetical model of a vascular mechanosensor containing ␤ENaC.
This model is based on the degenerin mechanosensor in the nematode Caenorhabditis elegans. In our model, we hypothesize that ␤ENaC is a component of the ion-conducting pore. The pore is tethered to the extracellular matrix (ECM) and possibly the cytoskeleton, either directly or indirectly. Gating of the mechanosensor by mechanical forces is proposed to lead to Na ϩ influx, membrane depolarization, and activation of downstream signaling, leading to VSMC contraction.
adjusting vascular resistance within 6 -25 s (3, 4, 16, 17) . In a previous study, we demonstrated the speed of myogenic regulation of RBF was slowed ϳ50% in the ␤ENaC m/m model, which did not match the 75% loss in afferent arteriolar myogenic tone shown in the present investigation. We considered the possibility that our previous results did not reflect the full importance of ␤ENaC-mediated myogenic control of RBF because of the potential confounding influence of TGF. The temporal separation in the onset of myogenic vs. TGF responses is not perfect. In addition, TGF may alter myogenic constriction (16, 17) . Therefore, to minimize the confounding influence of TGF and gain additional insight into the importance of the myogenic mechanism on RBF control, we examined renal hemodynamic responses to a step increase in pressure under conditions where the contribution of TGF to vascular resistance was suppressed following acute volume expansion (9, 18, 28, (35) (36) (37) . We avoided utilizing a more severe pharmacological approach to inhibit TGF, such as furosemide, since ␤ENaC m/m mice have compensatory responses for a loss of tubular Na ϩ and fluid reabsorption due to the importance of ␤ENaC in Na ϩ /H 2 0 transport in the distal nephron (27) . Furthermore, furosemide can lower blood pressure independent of diuretic actions (31) . Therefore, from our perspective, volume expansion to suppress the influence of TGF on vascular resistance was the best option. Consistent with our expectations, we found a greater deficit in the apparent myogenic speed in ␤ENaC m/m mice with volume expansion. These findings suggest that our in vivo findings (loss of myogenic regulation of RBF) parallel our in vitro findings (loss of myogenic constriction in afferent arterioles) in ␤ENaC m/m mice.
A limitation of the current study is that we are unable to compare the kinetics of the myogenic response between our in vivo and in vitro preparations. With the in vivo approach, we are able to assess the kinetics because we can elicit a rapid, single-step increase in renal perfusion pressure with ligation of the lower abdominal aorta. However, due to our experimental set-up of our in vitro preparation, we are not able to elicit a single-step increase in luminal pressure of consistent magnitude among samples. Multiple adjustments to the pressure generation system are required to achieve the 120-mmHg pressure at the arteriole perfusion pipette. This prevents an accurate dynamic assessment of the myogenic response in the in vitro preparation.
Potential involvement of compensatory responses to maintain volume homeostasis on renal myogenic responsiveness in ␤ENaC m/m? The loss in tubular Na ϩ and water retention in the ␤ENaC m/m model likely evokes compensatory hormonal responses needed to maintain blood volume/pressure status. The mostly likely compensatory changes would be in the renin-angiotensin system. Angiotensin II (ANG II) is indeed an important potentiator of renal myogenic constriction (20) . However, ANG II is likely to be elevated and thus not likely to account for loss of myogenic responsiveness. Aldosterone has been shown to suppress myogenic constriction in cerebral vessels, and thus may contribute to the loss of myogenic responsiveness (29) . However, previous findings from our laboratory showing transient silencing of ␤ENaC inhibits myogenic constriction in small renal arteries supports a role for ␤ENaC independent of compensatory responses to maintain volume homeostasis.
Potential pathogenic impact of loss of myogenic constriction. The fast nature of the myogenic response has led to the hypothesis that the myogenic response is a key protective mechanism against renal injury (23) . In a previous investigation, we found that ␤ENaC m/m mice have signs of renal inflammation, mild injury, and a small increase in blood pressure (6) . We speculate that loss of myogenic constriction could increase the susceptibility of the ␤ENaC m/m to injury or accelerate injury if a secondary stimulus, such as diabetes, end-stage renal disease, or greater increases in arterial pressure were superimposed. Understanding the importance of secondary factors on the protective ability of the myogenic response is an exciting area of future investigation.
In summary, the findings of the current investigation demonstrate that ␤ENaC is expressed in small renal arteries and arterioles. The myogenic response in afferent arterioles and myogenic control of whole kidney blood flow are weakened in mice with reduced levels of ␤ENaC. Our findings suggest ␤ENaC is an important mediator of renal myogenic constriction.
